Heterocyclic compounds useful as inhibitors of tyrosine kinases
AssigneeBoehringer Ingelheim Pharmaceuticals, Inc.
InventorsRoger John Snow, Donghong A. Gao, Daniel R. Goldberg, Abdelhakim Hammach, Daniel Kuzmich, Tina Marie Morwick, Neil Moss, Anthony S. Prokopowicz III, Robert D. Selliah, Hidenori Takahashi
Life of this patent
Estimating the term…